Cspc Pharmaceutical Group
(OTC) CSPCY
Cspc Pharmaceutical Group Financials at a Glance
Market Cap
$12.98B
Revenue (TTM)
$40.28B
Net Income (TTM)
$6.34B
EPS (TTM)
$0.19
P/E Ratio
24.29
Dividend
$0.12
Beta (Volatility)
0.49 (Low)
Dividend
$0.12
Beta (Volatility)
0.49 (Low)
Price
$4.50
Volume
3,799
Open
$4.49
Price
$4.50
Volume
3,799
Open
$4.49
Previous Close
$4.50
Daily Range
$4.49 - $4.54
52-Week Range
$2.32 - $5.83
Dividend
$0.12
Beta (Volatility)
0.49 (Low)
Price
$4.50
Volume
3,799
Open
$4.49
Previous Close
$4.50
Daily Range
$4.49 - $4.54
52-Week Range
$2.32 - $5.83
CSPCY News
CSPCY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cspc Pharmaceutical Group
Industry
Pharmaceuticals
Sector
Health CareEmployees
21,400
CEO
Cui Long Zhang
Website
www.cspc.com.hkHeadquarters
Shijiazhuang, 050035, CN
CSPCY Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
16%
Net Income Margin
15%
Return on Equity
11%
Return on Capital
12%
Return on Assets
9%
Earnings Yield
4.12%
Dividend Yield
0.03%
Payout Ratio
45.42%
Stock Overview
Market Cap
$12.98B
Shares Outstanding
2.88B
Volume
3.80K
Short Interest
0.00%
Avg. Volume
4.60K
Financials (TTM)
Gross Profit
$21.60B
Operating Income
$5.71B
EBITDA
$6.86B
Operating Cash Flow
$4.53B
Capital Expenditure
$2.68B
Free Cash Flow
$1.86B
Cash & ST Invst.
$8.25B
Total Debt
$507.33M
Cspc Pharmaceutical Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.83B
-77.2%
Gross Profit
$1.20B
-79.0%
Gross Margin
65.62%
N/A
Market Cap
$12.98B
N/A
Market Cap/Employee
$606.41K
N/A
Employees
21,400
N/A
Net Income
$351.20M
-77.2%
EBITDA
$3.48B
+82.5%
Quarterly Fundamentals
Net Cash
$9.21B
-21.1%
Accounts Receivable
$9.44B
-0.4%
Inventory
$2.87B
+4.3%
Long Term Debt
$158.75M
-23.2%
Short Term Debt
$336.25M
+61.3%
Return on Assets
8.85%
N/A
Return on Invested Capital
12.40%
N/A
Free Cash Flow
$289.99M
-33.8%
Operating Cash Flow
$455.84M
-69.8%